OKYO Pharma Limited (OKYO)

OKYO Pharma Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	4.22	1.56	0.83	4.05	2.7	6.88
Cash & Short-Term Investments	4.22	1.56	0.83	4.05	2.7	6.88
Cash Growth	327.51%	88.78%	-79.56%	49.79%	-60.73%	2807.98%
Other Receivables	0.02	1.89	0.58	0.98	0.88	0.08
Receivables	0.02	1.89	0.58	0.98	0.88	0.08
Prepaid Expenses	0.39	0.23	0.13	0.17	0.71	0.02
Total Current Assets	4.64	3.68	1.54	5.2	4.3	6.97
Property, Plant & Equipment	0	0	0	0.01	0.01	0.1
Total Assets	4.64	3.68	1.54	5.2	4.3	7.08
Accounts Payable	7.64	7.9	6.13	2.31	0.74	0.21
Accrued Expenses	-	1.24	1.19	2.65	0.61	1.46
Short-Term Debt	0.19	-	-	2.22	-	-
Current Portion of Leases	-	-	-	-	-	0.03
Other Current Liabilities	0.23	0.09	0.1	0.07	-	-
Total Current Liabilities	8.06	9.23	7.42	7.26	1.35	1.7
Long-Term Leases	-	-	-	-	-	0.06
Total Liabilities	8.06	9.23	7.42	7.26	1.35	1.77
Additional Paid-In Capital	151.23	146.72	143.11	131.39	123.98	91.91
Retained Earnings	-145.61	-143.02	-142.52	-125.7	-112.43	-99.4
Comprehensive Income & Other	-9.03	-9.24	-6.47	-7.74	-8.6	12.8
Shareholders' Equity	-3.42	-5.55	-5.88	-2.05	2.95	5.31
Total Liabilities & Equity	4.64	3.68	1.54	5.2	4.3	7.08
Total Debt	0.19	-	-	2.22	-	0.1
Net Cash (Debt)	4.03	1.56	0.83	1.83	2.7	6.78
Net Cash Growth	309.44%	88.78%	-54.82%	-32.23%	-60.16%	3211.98%
Net Cash Per Share	0.10	0.04	0.03	0.08	0.18	0.65
Filing Date Shares Outstanding	38.45	37.61	33.84	25.55	21.14	10.35
Total Common Shares Outstanding	38.45	36.02	33.34	25.52	21.14	10.35
Working Capital	-3.42	-5.55	-5.88	-2.06	2.94	5.27
Book Value Per Share	-0.09	-0.15	-0.18	-0.08	0.14	0.51
Tangible Book Value	-3.42	-5.55	-5.88	-2.05	2.95	5.31
Tangible Book Value Per Share	-0.09	-0.15	-0.18	-0.08	0.14	0.51
Machinery	0.01	0.01	0.01	0.02	0.01	0.01

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q